PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 15, 20240 citations

Supplementary Figure 5 from CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive Tumors

View Full Paper
SASophie ArcherPBPhillip M. BraileyMSMinjung Song

Key Points

Key points are not available for this paper at this time.

Abstract

Supplementary Figure 5: CB307 binding to cell-presented targets

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Archer et al. (2024) studied this question.

synapsesocial.com/papers/68e6f2a2b6db64358766d10chttps://doi.org/10.1158/1078-0432.25603495.v1
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Supplementary Figure 5 from CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive Tumors2024
  2. 2Supplementary Figure 4 from CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive Tumors2024
  3. 3Supplementary Figure 4 from CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive Tumors2024
  4. 4Supplementary Figure 1 from CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive Tumors2024
  5. 5Supplementary Figure 1 from CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive Tumors2024